MedGenome Stock

research.medgenome.comHealthcare / BioTech & PharmaFounded: 2013

MedGenome is a provider of personalized medicine and genomic solutions in immuno-oncology, diabetes, ophthalmology, cardiology and other rare diseases. Additionally, MedGenome's wet lab capabilities have allowed for solutions that enable pharma and biotech companies to accelerate early drug discovery pipelines as well as aid biomarker discoveries for companion diagnostics programs.

Register To Buy and Sell Shares

For more details on financing and valuation for MedGenome, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access MedGenome’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like MedGenome.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Mahesh Pratapneni
Group Chief Executive Officer & Co-Founder, Director
Somasekar Seshagiri
Chief (Genomics and Informatics) & Head (US Operations)
Hiranjith G H
Vice President & Head of Research Services
Dr. V L Ramprasad
Chief Executive Officer - India
Surajit Chakrabartty
Chief Financial Officer

Board Members

Dr. Felix Olale
Sam Santhosh
Neeraj Bhargava
Independent Director
Tejeshwi Sharma
Sequoia Capital

Frequently Asked Questions About MedGenome’s Stock

Can you buy MedGenome’s stock?
MedGenome is not publicly traded on NYSE or NASDAQ in the U.S. To buy MedGenome’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell MedGenome’s stock?
Yes, you can sell stock of a private company like MedGenome. Forge can help you sell your MedGenome stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is MedGenome’s stock price?
MedGenome is a privately held company and therefore does not have a public stock price. However, you may access MedGenome’s private market stock price with Forge Data.
What is MedGenome’s stock ticker symbol?
MedGenome does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

MedGenome Raises $50M To Map The Human Genome
Diagnostics and research startup MedGenome announced on Tuesday it raised $50 million led by life science-focused Novo Holdings, bringing total funding to $185.5 million. MedGenome, a California-based startup, leverages genomic sequencing platforms to aid in diagnostics and drug discovery.
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.